Tivity Health (TVTY) Stock Forecast, Price & News

Tivity Health (NASDAQ:TVTY) Frequently Asked Questions

Is Tivity Health a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tivity Health in the last twelve months. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Tivity Health stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TVTY, but not buy additional shares or sell existing shares.
View analyst ratings for Tivity Health or view top-rated stocks.

Are investors shorting Tivity Health?

Tivity Health saw a increase in short interest in April. As of April 30th, there was short interest totaling 3,330,000 shares, an increase of 21.5% from the April 15th total of 2,740,000 shares. Based on an average daily trading volume, of 907,500 shares, the days-to-cover ratio is currently 3.7 days. Approximately 7.7% of the shares of the stock are short sold.
View Tivity Health's Short Interest.

When is Tivity Health's next earnings date?

Tivity Health is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Tivity Health.

How were Tivity Health's earnings last quarter?

Tivity Health, Inc. (NASDAQ:TVTY) issued its quarterly earnings results on Thursday, May, 5th. The company reported $0.40 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.42 by $0.02. The company had revenue of $127.51 million for the quarter, compared to analysts' expectations of $132.21 million. Tivity Health had a trailing twelve-month return on equity of 75.94% and a net margin of 17.25%. The business's revenue for the quarter was up 18.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.40 earnings per share.
View Tivity Health's earnings history.

What guidance has Tivity Health issued on next quarter's earnings?

Tivity Health issued an update on its FY 2022 earnings guidance on Thursday, March, 24th. The company provided earnings per share guidance of $1.750-$1.840 for the period, compared to the consensus earnings per share estimate of $1.810. The company issued revenue guidance of $540 million-$580 million, compared to the consensus revenue estimate of $535.89 million.

What price target have analysts set for TVTY?

6 brokerages have issued 1-year target prices for Tivity Health's shares. Their forecasts range from $25.00 to $35.00. On average, they expect Tivity Health's share price to reach $30.80 in the next twelve months. This suggests that the stock has a possible downside of 4.4%.
View analysts' price targets for Tivity Health or view top-rated stocks among Wall Street analysts.

Who are Tivity Health's key executives?

Tivity Health's management team includes the following people:

• Mr. Richard M. Ashworth, Pres, CEO & Director (Age 47, Pay $1.7M)
• Mr. Adam C. Holland, Chief Financial Officer (Age 43, Pay $411.91k)
• Mr. Ryan M. Wagers, Chief Accounting Officer & Controller (Age 44, Pay $294.16k)
• Mr. Thomas E. Lewis, Chief Operating Officer (Age 57)
• Ms. Sarah Richardson, Chief Information Officer
• Mr. Matt Milanovich, VP of Investor Relations
• Mr. Joseph Raymond Bilbao, Chief Legal Officer & Corp. Sec. (Age 55)
• Jill Meyer, VP of Corp. Communications
• Mr. Jeremy Kunicki, Sr. VP of Corp. Devel.
• Ms. Bonnie Schirato, Chief People & Culture Officer

What is Richard Ashworth's approval rating as Tivity Health's CEO?

8 employees have rated Tivity Health CEO Richard Ashworth on Glassdoor.com. Richard Ashworth has an approval rating of 36% among Tivity Health's employees. This puts Richard Ashworth in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Tivity Health's key competitors?

Some companies that are related to Tivity Health include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), R1 RCM (RCM), LHC Group (LHCG), Amedisys (AMED), AMN Healthcare Services (AMN), CorVel (CRVL), MEDNAX (MD) and Cross Country Healthcare (CCRN).
View all of TVTY's competitors.

What other stocks do shareholders of Tivity Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tivity Health investors own include NVIDIA (NVDA), Energy Transfer (ET), Pfizer (PFE), Advanced Micro Devices (AMD), AT&T (T), (CGC), Sorrento Therapeutics (SRNE), Applied Materials (AMAT), Inovio Pharmaceuticals (INO) and Novavax (NVAX).

What is Tivity Health's stock symbol?

Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."

Who are Tivity Health's major shareholders?

Tivity Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (14.49%), Vanguard Group Inc. (9.76%), State Street Corp (3.06%), Dimensional Fund Advisors LP (1.78%), The Manufacturers Life Insurance Company (1.75%) and Goldman Sachs Group Inc. (1.72%).
View institutional ownership trends for Tivity Health.

Which institutional investors are selling Tivity Health stock?

TVTY stock was sold by a variety of institutional investors in the last quarter, including Healthcare of Ontario Pension Plan Trust Fund, Hawk Ridge Capital Management LP, Goldman Sachs Group Inc., Eagle Asset Management Inc., Vanguard Group Inc., Principal Financial Group Inc., Blair William & Co. IL, and Qube Research & Technologies Ltd.
View insider buying and selling activity for Tivity Health or view top insider-selling stocks.

Which institutional investors are buying Tivity Health stock?

TVTY stock was purchased by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Invesco Ltd., Hood River Capital Management LLC, The Manufacturers Life Insurance Company , Royce & Associates LP, EAM Investors LLC, Teacher Retirement System of Texas, and Victory Capital Management Inc..
View insider buying and selling activity for Tivity Health or or view top insider-buying stocks.

How do I buy shares of Tivity Health?

Shares of TVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tivity Health's stock price today?

One share of TVTY stock can currently be purchased for approximately $32.22.

How much money does Tivity Health make?

Tivity Health has a market capitalization of $1.61 billion and generates $481.25 million in revenue each year. The company earns $104.91 million in net income (profit) each year or $1.709990 on an earnings per share basis.

How many employees does Tivity Health have?

Tivity Health employs 380 workers across the globe.

When was Tivity Health founded?

Tivity Health was founded in 2017.

What is Tivity Health's official website?

The official website for Tivity Health is www.tivityhealth.com.

How can I contact Tivity Health?

Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The company can be reached via phone at (800) 869-5311, via email at [email protected], or via fax at 302-674-5266.